<!DOCTYPE html>
<html lang="en-us">
  <head>
	<meta name="generator" content="Hugo 0.85.0" />
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>fallingstar-Daily-rss | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>fallingstar-Daily-rss</span>
        <span>2024-09-15</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39272698/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Prospective Comparison of Nine Different Handheld Ultrasound (HHUS) Devices by Ultrasound Experts with Regard to B-Scan Quality, Device Handling and Software in Abdominal Sonography</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39272698-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: This is the first comprehensive study to directly compare different HHUS devices in a head-to-head manner. While the majority of the tested devices demonstrated satisfactory performance, notable discrepancies were observed between them. In particular, the B-scan quality exhibited considerable variation, which may have implications for the clinical application of HHUS. The findings of this study can assist in the selection of an appropriate HHUS device for specific &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39272752/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Impact of Structured Reporting of Lower Extremity CT Angiography on Report Quality and Workflow Efficiency</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39272752-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    We assessed the effects of structured reporting (SR) of lower extremity CT angiography (CTA) on report quality and workflow efficiency compared with conventional reports (CR). Surveys were conducted at an academic radiology department before and after the introduction of an SR template. Participants (n = 39, 21) rated report quality and report creation effort (1: very dissatisfied/low to 10: very satisfied/high) and whether SR represents an improvement over CR (1: completely disagree to &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39272856/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Cabozantinib Plus Nivolumab in Adult Patients with Advanced or Metastatic Renal Cell Carcinoma: A Retrospective, Non-Interventional Study in a Real-World Cohort/GUARDIANS Project</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39272856-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    INTRODUCTION: Combinations of immune-checkpoint inhibitors (ICIs) are the standard of care (SOC) for treatment-naive metastatic renal cell carcinoma (mRCC) patients. In this multicenter study, we evaluated the RW safety and efficacy of cabozantinib plus nivolumab in mRCC &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39272868/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Initial Trans-Arterial Chemo-Embolisation (TACE) Is Associated with Similar Survival Outcomes as Compared to Upfront Percutaneous Ablation Allowing for Follow-Up Treatment in Those with Single Hepatocellular Carcinoma (HCC) ≤ 3 cm: Results of a Real-World Propensity-Matched Multi-Centre Australian Cohort Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39272868-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Percutaneous ablation is recommended in Barcelona Clinic Liver Cancer (BCLC) stage 0/A patients with HCC ≤3 cm as a curative treatment modality alongside surgical resection and liver transplantation. However, trans-arterial chemo-embolisation (TACE) is commonly used in the real-world as an initial treatment in patients with single small HCC in contrast to widely accepted clinical practice guidelines which typically describe TACE as a treatment for intermediate-stage HCC. We performed &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39273014/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">PDCD10 Is a Key Player in TMZ-Resistance and Tumor Cell Regrowth: Insights into Its Underlying Mechanism in Glioblastoma Cells</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39273014-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Overcoming temozolomide (TMZ)-resistance is a major challenge in glioblastoma therapy. Therefore, identifying the key molecular player in chemo-resistance becomes urgent. We previously reported the downregulation of PDCD10 in primary glioblastoma patients and its tumor suppressor-like function in glioblastoma cells. Here, we demonstrate that the loss of PDCD10 causes a significant TMZ-resistance during treatment and promotes a rapid regrowth of tumor cells after treatment. PDCD10 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39273106/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">BMP4-Induced Suppression of Breast Cancer Metastasis Is Associated with Inhibition of Cholesterol Biosynthesis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39273106-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    We reported previously that in preclinical models, BMP4 is a potent inhibitor of breast cancer metastasis and that high BMP4 protein levels predict favourable patient outcomes. Here, we analysed a breast cancer xenograft with or without enforced expression of BMP4 to gain insight into the mechanisms by which BMP4 suppresses metastasis. Transcriptomic analysis of cancer cells recovered from primary tumours and phosphoproteomic analyses of cancer cells exposed to recombinant BMP4 revealed &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39273234/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Effects of Oxiris&lt;sup&gt;®&lt;/sup&gt; Therapy on Cytokine Elimination after a LPS Infusion-An Experimental Animal Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39273234-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The clinical effectiveness of Oxiris^(®), particularly in reducing cytokines, remains uncertain due to the limited data provided. This study explored and analyzed the application value of Oxiris^(®) endotoxin adsorption technology in a large animal model. Pigs received an intravenous LPS infusion. Six animals were treated 2 h after the infusion with an Oxiris^(®) hemadsorption using a pumpless extracorporeal technique for 6 h. Five animals served as controls. Cardiocirculatory &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39273340/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Drug Repurposing Approach to Identify Candidate Drug Molecules for Hepatocellular Carcinoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39273340-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Hepatocellular carcinoma (HCC) is the most prevalent primary liver cancer, with a high mortality rate due to the limited therapeutic options. Systemic drug treatments improve the patient&rsquo;s life expectancy by only a few months. Furthermore, the development of novel small molecule chemotherapeutics is time-consuming and costly. Drug repurposing has been a successful strategy for identifying and utilizing new therapeutic options for diseases with limited treatment options. This study aims &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39273499/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Peripheral Inflammation Featuring Eosinophilia or Neutrophilia Is Associated with the Survival and Infiltration of Eosinophils within the Tumor among Various Histological Subgroups of Patients with NSCLC</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39273499-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Immune activation status determines non-small cell lung cancer (NSCLC) prognosis, with reported positive/negative associations for T helper type 2 (TH2) responses, including allergen-specific IgE and eosinophils. Our study seeks to explore the potential impact of these comorbid immune responses on the survival rates of patients with NSCLC. Our retrospective study used data from the Data Warehouse of the German Center for Lung Research (DZL) and Lung Biobank at Thoraxklinik Heidelberg. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39273576/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">The Molecular and Immunological Landscape of Meningiomas</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39273576-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Meningiomas are the most common primary intracranial tumors in adults and typically have a slow-growing and benign nature. However, there is also a substantial subset of meningiomas that shows aggressive clinical behavior and is refractory to standard treatment modalities, which are still limited to surgery and/or radiotherapy. Despite intensive research, no systemic treatment options are yet available in the clinic for these challenging tumors, resulting in poor patient outcome. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39273646/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Anti-Inflammatory and Anti-(Lymph)angiogenic Properties of an ABCB5&#43; Limbal Mesenchymal Stem Cell Population</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39273646-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Corneal transparency and avascularity are essential for vision. The avascular cornea transitions into the vascularized conjunctiva at the limbus. Here, we explore a limbal stromal cell sub-population that expresses ABCB5 and has mesenchymal stem cell characteristics. Human primary corneal stromal cells were enriched for ABCB5 by using FACS sorting. ABCB5+ cells expressed the MSC markers CD90, CD73, and CD105. ABCB5+ but not ABCB5- cells from the same donor displayed evidence of pluripotency &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39274320/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Development of the International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC) Grade-Based Guidelines on the Surgical Treatment of Obesity Using Multimodal Strategies: Design and Methodological Aspects</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39274320-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: The prevalence of obesity is already a worldwide health concern. The development of straightforward guidelines regarding the whole available armamentarium (i.e., medical, endoscopic, and surgical interventions in conjunction with a guidance program) is paramount to offering the best multimodal approach to patients with obesity. Methods: The International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC) identified a panel of experts to develop &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39274363/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Age-Related Outcomes in Heart Failure with Mildly Reduced Ejection Fraction</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39274363-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Objective: This study investigates age-related differences and outcomes in patients hospitalized with heart failure with a mildly reduced ejection fraction (HFmrEF). Background: The characterization of patients with HFmrEF and the prognostic value of age has rarely been investigated. Methods: Patients with HFmrEF were retrospectively included at one institution between 2016 and 2022. The distribution of HF aetiology and prognostic outcomes were investigated comparing patients with ≤40, &gt;40 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39274400/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Mid-Term Migration Pattern of a Cemented Collared Anatomical Stem-A Retrospective Study Using EBRA-FCA</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39274400-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: Aseptic loosening is one of the leading causes of stem revision. Einzel Bild Röntgen Analyse-Femoral Component Analysis allows for the detection of distal stem migration, which is used as a predictive factor for implant longevity. This study aims to demonstrate the migration behavior of a cemented collared anatomical stem. Methods: This study retrospectively examined all patients who received a cemented Lubinus SP II stem (Waldemar Link, Hamburg, Germany) between 2003 and 2019. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39274457/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Feasibility and Safety of 3D-Navigated Trans-Sacral Bar Osteosynthesis for Fragility Fractures of the Sacrum: FIRST Clinical Experiences</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39274457-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: There has been an increasing number of fragility fractures of the sacrum in the recent decade. With rates of up to 28%, the complication rates after surgical treatment are still at an unacceptably high level, and new treatment strategies are urgently needed. Therefore, the purpose of this study was to evaluate the potential of 3D-navigated trans-sacral bar osteosynthesis in the surgical treatment of fragility fractures of the sacrum. Methods: Retrospectively, from 2017 to 2023, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39274611/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Dimensional Accuracy of Novel Vinyl Polysiloxane Compared with Polyether Impression Materials: An In Vitro Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39274611-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Transferring the intraoral situation accurately to the dental laboratory is crucial for fabricating precise restorations. This study aimed to compare the dimensional accuracy of a new hydrophilic quadrofunctional vinyl polysiloxane (VPS) and polyether (PE), in combination with different impression techniques (mono-phase single step or dual-phase single step). The reference model simulated a partially edentulous mandible. Stainless-steel precision balls were welded to specific teeth and were &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39275979/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Setting up an institutional OMERO environment for bioimage data: Perspectives from both facility staff and users</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39275979-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Modern bioimaging core facilities at research institutions are essential for managing and maintaining high-end instruments, providing training and support for researchers in experimental design, image acquisition and data analysis. An important task for these facilities is the professional management of complex multidimensional bioimaging data, which are often produced in large quantity and very different file formats. This article details the process that led to successfully implementing &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39276119/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Factors Influencing Long-term Outcomes After Matrix-Induced Autologous Chondrocyte Implantation: Long-term Results at 10 Years</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39276119-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The present study shows consistently good long-term clinical outcomes after MACI with a low revision rate and high patient satisfaction. BMI and number of previous knee surgeries may influence clinical outcomes and should be considered in patient selection and education. There is a correlation between graft structure, subchondral bone changes on magnetic resonance imaging, and long-term &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39276145/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">EuMAR stakeholder engagement: an analysis of medically assisted reproduction (MAR) data collection practices in EU countries†</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39276145-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    STUDY QUESTION: What are the current national medically assisted reproduction (MAR) data collection systems across EU Member States, and how can these countries contribute to a unique, cycle-by-cycle registry for the European Monitoring of Medically Assisted Reproduction (EuMAR) &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39276227/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Digital remote monitoring of chronic retinal conditions-A clinical future tool? : Remote monitoring of chronic retinal conditions</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39276227-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Remote monitoring could complement existing care structures for patients with chronic retinal diseases, especially AMD and DED. Promising systems are based on hyperacuity or optical coherence tomography, while patient-reported data are not commonly used; however, there is currently insufficient evidence justifying the use of remote monitoring systems in chronic retinal diseases in Europe and more research on the validation of remote monitoring systems is &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OwUyY8KpD">今天therapist说”off record, I enjoy talking to you”。我们用了很久聊了CBT循证，然后我给他看了一下我们昨天新闻发布，解释了临床试验意义。我说我们工作都...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-owuyy8kpd/">
    
    
    
    
    
      
    
    今天therapist说”off record, I enjoy talking to you”。我们用了很久聊了CBT循证，然后我给他看了一下我们昨天新闻发布，解释了临床试验意义。我说我们工作都是看chart。我觉得最近几次我们更像是同事讨论项目和数据，而不是在做therapy。  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OwWkdjfbv">周五晚上11点了同事们还在核对数据。我今天跟我therapist说到这点，他说这对你来说不是工作，而是passion。其实在HIV领域，这么多年我认识的同事朋友很多人都是...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-owwkdjfbv/">
    
    
    
    
    
      
    
    周五晚上11点了同事们还在核对数据。我今天跟我therapist说到这点，他说这对你来说不是工作，而是passion。其实在HIV领域，这么多年我认识的同事朋友很多人都是因为纯粹的passion而留在这个领域。尤其是现在，我看到每个数据点，都是一个活生生的人，对他们而言，经历HIV感染都是人生最大困境之一。  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OwXmc0v5b">Barouch组在Nature Med发表了一项HIV中和抗体（bNAbs）用于HIV治疗的临床试验结果，这是该研究组从恒河猴模型转型临床试验后第二篇中和抗体临床试验研究论文，之...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-owxmc0v5b/">
    
    
    
    
    
      
    
    Barouch组在Nature Med发表了一项HIV中和抗体（bNAbs）用于HIV治疗的临床试验结果，这是该研究组从恒河猴模型转型临床试验后第二篇中和抗体临床试验研究论文，之前的研究结果同样发表在了Nature Med上（<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->网页链接<!-- raw HTML omitted --><!-- raw HTML omitted -->）；这也是之前研究的后续研究，为HIV-1  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/OwUKJ34Yd">敦煌博物馆门口，有一家动物医院。一看就是专为牛、马、马喽这样的动物看病的，白领动物如狗、鹦鹉、蜥蜴之类，大概有更高级的对口医院。至于金领猫，恐怕是专属...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-owukj34yd/">
    
    
    
    
    
      
    
    敦煌博物馆门口，有一家动物医院。一看就是专为牛、马、马喽这样的动物看病的，白领动物如狗、鹦鹉、蜥蜴之类，大概有更高级的对口医院。至于金领猫，恐怕是专属家庭医生了吧？ <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/OwVSUqKBx">路遇一家孟婆粉……店主好像忘了开店了 查看图片 - 转发 @马伯庸:&amp;ensp;敦煌博物馆门口，有一家动物医院。一看就是专为牛、马、马喽这样的动物看病的，白领动物...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-owvsuqkbx/">
    
    
    
    
    
      
    
    路遇一家孟婆粉……店主好像忘了开店了 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->查看图片<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@马伯庸<!-- raw HTML omitted -->: 敦煌博物馆门口，有一家动物医院。一看就是专为牛、马、马喽这样的动物看病的，白领动物如狗、鹦鹉、蜥蜴之类，大概有更高级的对口医院。至于金领猫 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ox0dDthdx">🔻看了第四局，年轻人打的挺好的。#王楚钦vs林诗栋#</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ox0ddthdx/">
    
    
    
    
    
      
    
    🔻看了第四局，年轻人打的挺好的。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#王楚钦vs林诗栋#<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ox0eD7ad6">但是有些有责任核实信息的有影响力帐号也跟着在这儿欢呼“外国人整顿相亲市场”了，就没意思了，骗骗自己就行了呗，还真骗哥们儿啊？//@包容万物恒河水:其实也没...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ox0ed7ad6/">
    
    
    
    
    
      
    
    但是有些有责任核实信息的有影响力帐号也跟着在这儿欢呼“外国人整顿相亲市场”了，就没意思了，骗骗自己就行了呗，还真骗哥们儿啊？//<!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->:其实也没啥，一种创作思路嘛。除了增加有些哥们儿的焦虑以外也没有什么别的坏处。毕竟不是一个赛道的。<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻视频1帐号 C妹在成都，抖音118.3万粉。<!-- raw HTML omitted -->🔻视频2帐号 JC在成都，抖音111.9万粉。<!-- raw HTML omitted -->🔻视频3帐号 阿珍在北京，抖音133.7万粉。<!-- raw HTML omitted -->🔻视频4帐号 LUNA在广州，抖音159.9万粉。<!-- raw HTML omitted -->🔻这些帐号商务合作帐号联系人一样，有业务需求的，联系一个就行了，省事省心。 &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/639b">https://tvax3.sinaimg.cn/large/639b</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ox0g2hiTF">🔻印度的公路塌方都很有辨析度。🔻via 火山迷灾害资讯网#热门视频# 包容万物恒河水的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ox0g2hitf/">
    
    
    
    
    
      
    
    🔻印度的公路塌方都很有辨析度。<!-- raw HTML omitted -->🔻via 火山迷灾害资讯网<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#热门视频#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->包容万物恒河水的微博视频<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->&lt;div style=&ldquo;clear: &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ox0Q8rghy">你怎么知道我买了原价的哈立德1礼包？//@许诺不想说话:包姐别急，早晚会有属于你的拉夫驾着巨大天燕90来迎娶你[doge] - 转发 @包容万物恒河水:&amp;ensp;🔻互联网...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ox0q8rghy/">
    
    
    
    
    
      
    
    你怎么知道我买了原价的哈立德1礼包？//<!-- raw HTML omitted -->@许诺不想说话<!-- raw HTML omitted -->:包姐别急，早晚会有属于你的拉夫驾着巨大天燕90来迎娶你<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻互联网上每个群体，都能匹配到适合自己的伏拉夫。 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ox0rMf5SR">伊戈尔·维克托罗维奇·普济克在顿涅茨克名气挺大，现在是上校，话说 DNR 内部丑闻也不少，仔细想想那么多战斗英雄陆陆续续是怎么被暗杀的。很多人因为这件事曝...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ox0rmf5sr/">
    
    
    
    
    
      
    
    伊戈尔·维克托罗维奇·普济克在顿涅茨克名气挺大，现在是上校，话说 DNR 内部丑闻也不少，仔细想想那么多战斗英雄陆陆续续是怎么被暗杀的。很多人因为这件事曝光，又把拉塞尔·本特利案联系在了一起。<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@呦吼啊呦吼呦吼<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted -->#俄乌局势#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%BF%84%E4%B9%8C%E5%B1%80%E5%8A%BF%E6%96%B0%E8%BF%9B%E5%B1%95%23&amp;amp;extparam=%23%E4%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%BF%84%E4%B9%8C%E5%B1%80%E5%8A%BF%E6%96%B0%E8%BF%9B%E5%B1%95%23&amp;amp;extparam=%23%E4%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ox0vNjVFP">🔻互联网上每个群体，都能匹配到适合自己的伏拉夫。</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ox0vnjvfp/">
    
    
    
    
    
      
    
    🔻互联网上每个群体，都能匹配到适合自己的伏拉夫。  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ox0yXwfiP">🔻谢谢守夜人，晚安。 [图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ox0yxwfip/">
    
    
    
    
    
      
    
    🔻谢谢守夜人，晚安。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ox14PCnBL">🔻俄罗斯国防部官网：🔻“俄联邦国防部长别洛索夫已命令：俄联邦国防部副部长兼俄联邦武装力量军事政治总局局长维克托-戈列米金上将、俄罗斯联邦武装力量总...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ox14pcnbl/">
    
    
    
    
    
      
    
    🔻俄罗斯国防部官网：<!-- raw HTML omitted -->🔻“俄联邦国防部长别洛索夫已命令：俄联邦国防部副部长兼俄联邦武装力量军事政治总局局长维克托-戈列米金上将、俄罗斯联邦武装力量总参谋长兼俄罗斯联邦国防部第一副部长瓦列里-格拉西莫夫陆军上将，立即与俄罗斯联邦安全局军事反情报司一道，尽快处理与两名呼号为‘欧内斯特’和‘康斯坦丁’的军人死 亡 有 关 的 案件。”<!-- raw HTML omitted -->🔻众所周知，别洛索夫领受着普京的任务，正在俄罗斯国防部内大刀阔斧清理门户。<!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/639b1bfbly1htnsjne50rj20p017n7pd.jpg%22">https://tvax1.sinaimg.cn/large/639b1bfbly1htnsjne50rj20p017n7pd.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ox1ehtrGz">打雷呢，没办法，打战雷吧。//@bbq77882011:包姐，2点多了，还没睡啊？ - 转发 @包容万物恒河水:&amp;ensp;🔻俄罗斯国防部官网：🔻“俄联邦国防部长别洛索夫已命...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ox1ehtrgz/">
    
    
    
    
    
      
    
    打雷呢，没办法，打战雷吧。//<!-- raw HTML omitted -->@bbq77882011<!-- raw HTML omitted -->:包姐，2点多了，还没睡啊？<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻俄罗斯国防部官网：<!-- raw HTML omitted -->🔻“俄联邦国防部长别洛索夫已命令：俄联邦国防部副部长兼俄联邦武装力量军事政治总局局长维克托-戈列米金上将、俄罗斯联邦武装力量总参谋长兼俄罗斯联邦国防部第一副部长瓦列里-格拉西莫夫陆军上将，立即与俄罗斯联邦安全局军事反情报司一道，尽快处理与两名呼号为‘欧内斯特’和‘康斯坦丁’的军人死 亡 有 关 的 案件。”<!-- raw HTML omitted -->🔻众所周知，别洛索夫领受着普京的任务，正在俄罗斯国防部内大刀阔斧清理门户。&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/639b1bf">https://tvax3.sinaimg.cn/large/639b1bf</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ox1xZBA9U">新官上任三把火 - 转发 @包容万物恒河水:&amp;ensp;🔻俄罗斯国防部官网：🔻“俄联邦国防部长别洛索夫已命令：俄联邦国防部副部长兼俄联邦武装力量军事政治总局局...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ox1xzba9u/">
    
    
    
    
    
      
    
    新官上任三把火<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻俄罗斯国防部官网：<!-- raw HTML omitted -->🔻“俄联邦国防部长别洛索夫已命令：俄联邦国防部副部长兼俄联邦武装力量军事政治总局局长维克托-戈列米金上将、俄罗斯联邦武装力量总参谋长兼俄罗斯联邦国防部第一副部长瓦列里-格拉西莫夫陆军上将，立即与俄罗斯联邦安全局军事反情报司一道，尽快处理与两名呼号为‘欧内斯特’和‘康斯坦丁’的军人死 亡 有 关 的 案件。”<!-- raw HTML omitted -->🔻众所周知，别洛索夫领受着普京的任务，正在俄罗斯国防部内大刀阔斧清理门户。<!-- raw HTML omitted -->&lt;img style=&quot;&quot;  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OwWkQ6m1n">久保用大姐手機拍的自拍照 [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-owwkq6m1n/">
    
    
    
    
    
      
    
    久保用大姐手機拍的自拍照 <!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OwYwZETGY">怎麼這麼好看啊！ [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-owywzetgy/">
    
    
    
    
    
      
    
    怎麼這麼好看啊！ <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OwXsPnauM">久保史绪里#久保史绪里手机博# 2024.09.14 13:57「时钟」早上好今天也努力吧今早时隔许久地起来得很干脆呢虽然也会有害怕起床的日子和很难起床的日子但是要努力...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-owxspnaum/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%258">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OwXtEdO8q">久保史绪里#shiorigram# 被找到了🫣 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-owxtedo8q/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->被找到了🫣 &lt;img &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OwYls0ist">久保史绪里[抱一抱] - 转发 @長亭梅:&amp;ensp;梅泽美波#梅泽美波# 夏のツアー、完走しました乃木坂で過ごす夏はいつも、単純には終われません。感情が 凄まじく動く...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-owyls0ist/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img alt=&quot;[抱一抱]&quot; src=&ldquo;<a href="https://h5.sinaimg.cn/m/emoticon/icon/default/co_a1hug-f3910d0e88.png%22">https://h5.sinaimg.cn/m/emoticon/icon/default/co_a1hug-f3910d0e88.png&quot;</a> style=&ldquo;width:1em; height:1em;&rdquo; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OwYqycZrD">久保史绪里[亲亲] - 转发 @特蕾纱熊猫観察会:&amp;ensp;池田瑛纱#terepantalk# 5566｜2024-09-14 20:04:26｜图片 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-owyqyczrd/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OwYrvzm52">久保史绪里[哇] - 转发 @特蕾纱熊猫観察会:&amp;ensp;池田瑛纱#terepantalk# 5567｜2024-09-14 20:04:45｜图片 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-owyrvzm52/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;blockquo &hellip;
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

